abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

このページは 日本語 では利用できません。English で表示されています

記事

2012年7月13日

著者:
Adeola Ajakaiye, BusinessDay [Nigeria]

Pfizer presents N19.6m to Kano drug test victim [Nigeria]

The Healthcare Meningitis Trust Fund, a corporate entity floated jointly by Pfizer Incorporated, and Kano State government, has presented a monetary compensation of N19.6 million to one of the victims of the Trovan drug in Kano. The beneficiary, Mohammed Mustapha, is the third batch of victims of the controversial drug test that have been compensated in the out-of-court settlement reached by parties involved in the dispute.

タイムライン